743 related articles for article (PubMed ID: 27780585)
1. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling negatively regulates activity of an olfactory receptor in an odorant-dependent manner.
Yu Y; Zhang C
Neuroscience; 2014 Sep; 275():89-101. PubMed ID: 24928349
[TBL] [Abstract][Full Text] [Related]
4. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2.
Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA
Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237
[TBL] [Abstract][Full Text] [Related]
5. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
6. P2Y receptor-mediated inhibition of voltage-activated Ca(2+) currents in PC12 cells.
Vartian N; Boehm S
Eur J Neurosci; 2001 Mar; 13(5):899-908. PubMed ID: 11264662
[TBL] [Abstract][Full Text] [Related]
7. Purinergic and pyrimidinergic receptors as potential drug targets.
Williams M; Jarvis MF
Biochem Pharmacol; 2000 May; 59(10):1173-85. PubMed ID: 10736418
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.
Jacobson KA; Balasubramanian R; Deflorian F; Gao ZG
Purinergic Signal; 2012 Sep; 8(3):419-36. PubMed ID: 22371149
[TBL] [Abstract][Full Text] [Related]
9. Impact of ectoenzymes on p2 and p1 receptor signaling.
Kukulski F; Lévesque SA; Sévigny J
Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
[TBL] [Abstract][Full Text] [Related]
10. Extracellular ATP-induced calcium signaling in mIMCD-3 cells requires both P2X and P2Y purinoceptors.
Xia SL; Wang L; Cash MN; Teng X; Schwalbe RA; Wingo CS
Am J Physiol Renal Physiol; 2004 Aug; 287(2):F204-14. PubMed ID: 15068972
[TBL] [Abstract][Full Text] [Related]
11. Purinergic signalling in the kidney: In physiology and disease.
Monaghan MT; Bailey MA; Unwin RJ
Biochem Pharmacol; 2021 May; 187():114389. PubMed ID: 33359067
[TBL] [Abstract][Full Text] [Related]
12. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
13. Activation of ERK1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation.
da Cruz CM; Ventura AL; Schachter J; Costa-Junior HM; da Silva Souza HA; Gomes FR; Coutinho-Silva R; Ojcius DM; Persechini PM
Br J Pharmacol; 2006 Feb; 147(3):324-34. PubMed ID: 16341234
[TBL] [Abstract][Full Text] [Related]
14. Purinergic mechanisms in neuroinflammation: An update from molecules to behavior.
Beamer E; Gölöncsér F; Horváth G; Bekő K; Otrokocsi L; Koványi B; Sperlágh B
Neuropharmacology; 2016 May; 104():94-104. PubMed ID: 26384652
[TBL] [Abstract][Full Text] [Related]
15. Extracellular nucleotides differentially regulate interleukin-1beta signaling in primary human astrocytes: implications for inflammatory gene expression.
John GR; Simpson JE; Woodroofe MN; Lee SC; Brosnan CF
J Neurosci; 2001 Jun; 21(12):4134-42. PubMed ID: 11404398
[TBL] [Abstract][Full Text] [Related]
16. [Nucleotide receptors--structure and function, history and perspectives].
Barańska J
Postepy Biochem; 2014; 60(4):424-37. PubMed ID: 25807822
[TBL] [Abstract][Full Text] [Related]
17. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
18. Effects of purine and pyrimidine nucleotides on intracellular Ca2+ in human eosinophils: activation of purinergic P2Y receptors.
Mohanty JG; Raible DG; McDermott LJ; Pelleg A; Schulman ES
J Allergy Clin Immunol; 2001 May; 107(5):849-55. PubMed ID: 11344352
[TBL] [Abstract][Full Text] [Related]
19. P2 purinoceptors: Renal pathophysiology and therapeutic potential.
Booth JW; Tam FW; Unwin RJ
Clin Nephrol; 2012 Aug; 78(2):154-63. PubMed ID: 22790461
[TBL] [Abstract][Full Text] [Related]
20. Molecular recognition at purine and pyrimidine nucleotide (P2) receptors.
Jacobson KA; Costanzi S; Ohno M; Joshi BV; Besada P; Xu B; Tchilibon S
Curr Top Med Chem; 2004; 4(8):805-19. PubMed ID: 15078212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
